Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medivation Inc.

Division of Pfizer Inc.
www.medivation.com

Latest From Medivation Inc.

Lynparza Gets First Mover Advantage In BRCA-Positive Breast Cancer

AstraZeneca and Merck & Co hope to advance Lynparza quickly in prostate and pancreatic cancers after getting first mover advantage in metastatic breast cancer.

Approvals Commercial

Scrip 100 Analysis: Sales Up, Profits Down – But Is It Real?

Bellwethers tell you something, but to gauge the health of the pharmaceutical industry, you really need the Scrip 100. For FY 2016, it looks like drug sales are up again and profits are down. But is this what's actually going on?

Scrip 100 Sales & Earnings

Pfizer Says Big Deals Create Value & 10 Other Notable Q3 Moments

Pfizer's third quarter earnings call covered a lot of ground, from pipeline updates, management's latest thinking on M&A, and strategic options for consumer healthcare, to industry trends like Amazon entering the drug distribution arena.

Sales & Earnings Deals

Pharma Q3 Results Preview: Pfizer, Allergan, Sanofi, Teva & AstraZeneca

Pfizer’s CEO will likely shed more light on the company’s on-off-on attitude towards its consumer health business, while Allergan will certainly have a lot of explaining to do regarding its Restasis patent protection strategy. Sanofi, Teva and AstraZeneca are also scheduled to report Q3 results in the coming days. Scrip outlines the key issues to watch for.

Sales & Earnings Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • David T Hung, MD, Pres. & CEO
    Jennifer Jarrett, CFO
    Joseph Lobacki, Chief Commercial Officer
    Marion McCourt, COO
  • Contact Info
  • Medivation Inc.
    Phone: (415) 543-3470
    525 Market St.
    36th Fl.
    San Francisco, CA 94105
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register